Stephens Inc’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,000
Closed -$32K 1284
2024
Q3
$32K Hold
1,000
﹤0.01% 1287
2024
Q2
$82.1K Hold
1,000
﹤0.01% 1245
2024
Q1
$145K Hold
1,000
﹤0.01% 1200
2023
Q4
$92.1K Hold
1,000
﹤0.01% 1157
2023
Q3
$165K Hold
1,000
﹤0.01% 1067
2023
Q2
$63.2K Buy
+1,000
New +$60.6K ﹤0.01% 1153

Other funds holding CDLX

Stephens Inc's CDLX Position: Q4 2024 in Review

Stephens Inc sold out of Cardlytics (CDLX) in Q4 2024, closing a stake of 1,000 shares — an estimated $32K sold.

Stephens Inc first reported a position in CDLX in Q2 2023 and held it in 6 quarters. The position peaked at $165K in Q3 2023. 108 funds tracked by Wall St. Rank hold CDLX as of Q4 2024.

  • Stephens Inc reported no remaining Cardlytics position as of Q4 2024 after selling out during the quarter.
  • Stephens Inc sold 1,000 Cardlytics shares in Q4 2024, an estimated $32K.
  • Stephens Inc first reported a position in Cardlytics in Q2 2023 and held it in 6 quarters.
  • Stephens Inc's Cardlytics position peaked at $165K in Q3 2023.
  • 108 funds tracked by Wall St. Rank held Cardlytics as of Q4 2024.

Based on Stephens Inc's 13F filing for Q4 2024, filed 28 Jan 2025.